by Team Small News | Aug 9, 2025 | Pfizer, Pharma, Zydus
Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market.... by Team Small News | Aug 8, 2025 | Mankind, Pfizer, Pharma
The burn pain market is a growing industry that is expected to expand due to the increasing incidence of burn injuries worldwide. According to DelveInsight, the market is driven by the rising demand for effective pain management therapies for burn patients. Burn pain... by Team Small News | Aug 8, 2025 | Pfizer, Pharma
CureVac, a German biotechnology company, and GlaxoSmithKline (GSK) have agreed to resolve a patent dispute litigation with Pfizer and BioNTech related to COVID-19 vaccine technology. The dispute centered on the use of messenger RNA (mRNA) technology, which is a key... by Team Small News | Aug 7, 2025 | Pfizer, Pharma
The Global Steroid Implant Market Study, conducted by HTF Market Intelligence, provides a comprehensive analysis of the market from 2025 to 2033. The report spans over 143 pages and covers the product and industry scope, market prognosis, and status. The market is... by Team Small News | Aug 3, 2025 | Pfizer, Pharma
Pfizer CEO Albert Bourla is expected to attend a fundraiser for President Trump’s super PAC, MAGA Inc., at his golf club in Bedminster, New Jersey. The event aims to raise $25 million. However, the meeting comes at an interesting time, as President Trump has... by Team Small News | Jul 12, 2025 | Cipla, Dr Reddy's, Lupin, Pfizer, Pharma
The Global Digoxin Market study, recently introduced by HTF MI, provides a comprehensive overview of the product and industry scope, as well as an in-depth analysis of the market outlook and status from 2025 to 2031. The market is segmented by key regions, including...